| Similar Articles |
|---|
 |
The Motley Fool
August 31, 2011
Harsh Chauhan |
Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion.   |
The Motley Fool
December 29, 2011
Harsh Chauhan |
Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now. |
The Motley Fool
December 9, 2011
Harsh Chauhan |
Medtronic Regains Its Footing Medtronic comes up with a strong quarter. |
The Motley Fool
February 17, 2005
Stephen D. Simpson |
Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock? |
The Motley Fool
June 6, 2011
Matt Koppenheffer |
Could Medtronic Double Your Money? Is it high time to add Medtronic's stock to your portfolio? |
The Motley Fool
May 26, 2005
Stephen D. Simpson |
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? |
The Motley Fool
November 18, 2004
W.D. Crotty |
Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy. |
The Motley Fool
August 18, 2011
Todd Wenning |
What Does Medtronic Do With Its Free Cash? Is it a good steward of shareholder capital? |
The Motley Fool
August 18, 2005
Stephen D. Simpson |
Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay. |
The Motley Fool
August 24, 2011
Arundhati Parmar |
Growth Is the Deity Medtronic CEO Omar Ishrak Will Worship CEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company. |
The Motley Fool
August 24, 2011
Brian Orelli |
Growth, but Not Great Growth Medtronic's growth comes with lower margins. |
The Motley Fool
May 25, 2011
Brian Orelli |
No Red Carpet for Medtronic's New CEO Omar Ishrak, Medtronic's newly-appointed CEO, looks like he has his work cut out for him trying to get the medical-device maker growing again. |
The Motley Fool
May 25, 2005
W.D. Crotty |
Medtronic's Sneak Preview The medical technology company, a 26-bagger, turns in another strong quarter and fiscal year, then offers quite an outlook. |
The Motley Fool
November 18, 2008
Brian Orelli |
No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy. |
The Motley Fool
January 26, 2005
Stephen D. Simpson |
St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains. |
The Motley Fool
February 17, 2009
Brian Orelli |
Investors Heart Medtronic The leaner company is more lovable. |
The Motley Fool
February 12, 2004
Jeff Hwang |
Rockin' Medtronic The world's premier medical device maker keeps on growing. |
The Motley Fool
August 20, 2008
Brian Orelli |
Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market. |
The Motley Fool
October 21, 2010
Anand Chokkavelu |
6 Health-Care Stocks Near 52-Week Lows Here are the largest health care equipment and services companies (by market cap) that are hugging 52-week lows: Medtronic... Covidien... Stryker... Becton, Dickinson and Company... McKesson... Cardinal Health... |
The Motley Fool
August 25, 2009
Brian Orelli |
Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again. |
The Motley Fool
January 6, 2005
Stephen D. Simpson |
Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past. |
The Motley Fool
August 4, 2006
Stephen D. Simpson |
Medtronic's Shock to the System Its guidance cuts rattled the med-tech industry, but long-term trends remain positive. While the going may be tougher now in the ICD space, it's still an attractive long-term opportunity, and investors may want to start looking around for bargains. |
The Motley Fool
August 22, 2007
Ryan Fuhrmann |
Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%. |
The Motley Fool
February 24, 2010
Brian Orelli |
Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products. |
The Motley Fool
August 24, 2010
Brian Orelli |
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. |
The Motley Fool
May 25, 2010
Brian Orelli |
Medtronic Gets Tossed Out With the Bathwater A bad day to report good news. |
The Motley Fool
July 6, 2011
Arundhati Parmar |
Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy? Jettisoning the spinal business may not be easy. |
BusinessWeek
May 29, 2006
Gene G. Marcial |
Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast. |
The Motley Fool
October 17, 2005
Stephen D. Simpson |
A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it. |
The Motley Fool
November 15, 2007
Rich Smith |
Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly. |
The Motley Fool
October 31, 2011
Matt Koppenheffer |
3 Stocks That Other Investors Are Overlooking, but You Shouldn't There are a lot of investors avoiding these three stocks for a very bad reason. Don't fall into the same trap. |
The Motley Fool
August 6, 2011
Arundhati Parmar |
Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets. |
The Motley Fool
January 18, 2011
Russ Krull |
Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold? |
The Motley Fool
November 17, 2010
Bryan Hinmon |
Rising Star Buy: Medtronic Find out why this medical technology giant takes a place in our Un Portfolio. |
The Motley Fool
August 6, 2010
Bryan Hinmon |
Moat Report Card: Medtronic This medical supplier's definitely got a heartbeat. |
The Motley Fool
May 24, 2006
Stephen D. Simpson |
Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment. |
The Motley Fool
February 20, 2008
Brian Orelli |
Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future. |
The Motley Fool
November 18, 2011
Brian Orelli |
Medtronic: Cutting Fat and Growing Margins The company announces that it has sold Physio-Control to private-equity fund Bain Capital. |
The Motley Fool
August 23, 2006
Stephen D. Simpson |
Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution. |
The Motley Fool
November 9, 2005
Stephen D. Simpson |
Greatbatch Keeps Growth Pumping Demand for implantable medical electronics keeps this battery and component maker humming. Investors new to this stock and/or medical technology in general will need to exercise some patience. |
The Motley Fool
May 12, 2011
Arundhati Parmar |
Analysts: Medtronic CEO Omar Ishrak Good Choice Ishrak represents a change at Medtronic. |
The Motley Fool
October 16, 2007
Billy Fisher |
A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low. |
The Motley Fool
February 24, 2009
Brian Orelli |
Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day. |
The Motley Fool
December 13, 2011
Dan Caplinger |
Has Boston Scientific Become the Perfect Stock? Since we looked at Boston Scientific last year, the maker of medical devices has gotten up off the mat and quadrupled its score. |
The Motley Fool
February 22, 2006
Stephen D. Simpson |
Medtronic's Minor Miss Sluggish sales in several market categories might spook investors. |
The Motley Fool
July 20, 2005
Stephen D. Simpson |
Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that. |
The Motley Fool
April 23, 2011 |
St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask. |
The Motley Fool
January 18, 2012
Dan Caplinger |
Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
There Are Better Opportunities Than Boston Scientific Let's take a look. By the numbers, Abbott, Medtronic, and Johnson & Johnson all look more compelling than Boston Scientific. |
The Motley Fool
March 3, 2011
Bryan Hinmon |
Medtronic's Moat Is Strengthening Lessons from an interview with Medtronic CFO Gary Ellis. |
